Correction to: Phase I–II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment …

Kurt A Jaeckle,SK Anderson,Erin L Twohy,Jesse G Dixon,Caterina Giannini,Robert Jenkins,Merrill J Egorin,Jann N Sarkaria,Paul D Brown,PJ Flynn,John Schwerkoske,Jan C Buckner,Evanthia Galanis

Journal of neuro-oncology（2019）

引用 0|浏览4

暂无评分

摘要

This corrects the article" PHASE I-II TRIAL OF IMATINIB MESYLATE (GLEEVEC; STI571) IN TREATMENT OF RECURRENT OLIGODENDROGLIOMA AND MIXED OLIGOASTROCYTOMA. NORTH CENTRAL CANCER TREATMENT GROUP STUDY N0272 (ALLIANCE/NCCTG)" in J Neurooncol, volume 143 on page 573.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要